House committee plans hearing on Chinese biotech competition as tensions mount
The House’s Select Committee on the Chinese Communist Party is meeting next week in Boston to discuss Chinese competition in biotech and national security.
The hearing comes weeks after a draft bill introduced by Committee Chair Mike Gallagher (R-WI) and others singled out several Chinese biotechs as “companies of concern.” The legislation would ban federally funded providers from doing business with Chinese companies, including WuXi AppTec and the genomics giant BGI Group. A similar bill with bipartisan backing has been introduced in the Senate.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.